Statistics
Publications
11
Citations
973
H-Index
11
Active since
2001
Xing Li is an author at Pfizer (United States) specializing in medicinal chemistry, pharmacy, and drug discovery.
Publications per year
2001–2025
11
11
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
Sho Iketani, F. Forouhar, Hengrui Liu et al. · Nature Communications · 2021 · 114 citations · Full text
1–5 of 11